COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024
18/10/2024
CONSHOHOCKEN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2024 financial results on Thursday, Oct. 31, 2024, prior to the [...]
Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024
18/10/2024
ORANGE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2024 financial results on Tuesday, Oct. 29, 2024, after market close. Following the release, [...]
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
18/10/2024
NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]
UPDATE -- Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition
18/10/2024
Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be approximately +$270 [...]
Phase III trial results of novel triple combination pill for hypertension published in The Lancet
18/10/2024
Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual therapy, with good [...]
ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer
18/10/2024
ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer Cambridge UK , 18 October 2024 – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront of genetic therapies, [...]
KFSHRC Leads Healthcare Intelligence in Diagnostics and Patient Care
18/10/2024
RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is contributing to global healthcare innovation, leveraging artificial intelligence (AI) and [...]
Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
18/10/2024
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, Oct. 18, [...]
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
18/10/2024
If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment with Kisqali ® ( [...]
Le KFSHRC présente ses dernières innovations et solutions de santé à l’occasion de la Global Health Exhibition 2024
18/10/2024
RIYAD, Arabie saoudite, 18 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) participera comme principal sponsor (Platine) à l’édition 2024 du Forum mondial de la santé ( [...]
Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition
18/10/2024
Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be approximately +$270 [...]
Nxera Pharma to Host R&D Day 2024
18/10/2024
Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Date : Wednesday, 6 November 2024 [...]
Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors
18/10/2024
Bagsværd, Denmark, 18 October 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending approval of [...]
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
18/10/2024
Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177 Lu) Companies enter into an additional manufacturing and supply agreement for NTP to produce and [...]
Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise
18/10/2024
DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), l’un des principaux organismes internationaux de recherche sous contrat (CRO), a annoncé aujourd’hui la publication du premier rapport [...]
Telix Files Form 20-F Registration Statement for Nasdaq ADS
17/10/2024
MELBOURNE, Australia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with [...]
Laguna Treatment Center Sets Standard for Veteran Addiction Care in Southern California with New PsychArmor Certification
17/10/2024
ALISO VIEJO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Laguna Treatment Center is among an elite group of addiction treatment providers who have earned Veteran Ready status from PsychArmor, a leader in military culture [...]
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
17/10/2024
Independent Data Safety and Monitoring Board Endorsed Dose Escalation and Broadening of Eligibility Criteria; Cohort 2 Now Enrolling Initial Data from Cohort 1 to be Reported in December 2024 Highlights Recently [...]
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
17/10/2024
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]

Pages